A B S T R A C T A preparative scheme has been developed for the purification of a trace protein in human serum exhibiting nonsuppressible insulin-like activity (NSILA). This scheme consisted of (a) adsorption chromatography of serum utilizing the sulfonic acid polystyrene resin, Dowex 50, at pH 6.8; (b) G-200 gel filtration at pH 8.9; and (c) acrylamide gel electrophoresis in a discontinuous preparative system. Throughout all procedures, NSILA fractionated as a single molecular species approximating 90.000 mol wt. The purified protein exhibited a single band by disk gel electrophoresis, an isoelectric pH approximating 6.2, doublet bands of 90,000 and 92,000 mol wt by analytical sodium dodecyl sulfate gel electrophoresis, and a biologic specific activity approximating 50 mU/mg. Serum somatomedin (sulfation factor) activity did not fractionate with NSILA in this scheme, and partially purified NSILA did not stimulate radiosulfate uptake into hypophysectomized rat costal cartilage. This protein appears to represent the major constituent of serum NSILA: its purification and partial characterization provides the first step towards elucidation of its metabolic role.
INTRODUCTION
It is generally recognized that serum contains one or more substances, in addition to insulin and proinsulin, that exhibit insulin-like biological activity when added in vitro or injected in vivo (1) (2) (3) (4) . This insulin-like activity has been studied in several pathophysiological states and has been referred to by at least five different terms (2, (5) (6) (7) . In spite of considerable research effort, the mo- Received for publication 24 February 1975 and in revised form 17 July 1975. lecular nature and biological significance of this activity remains poorly defined. The principal problem resides in the fact that purification leading to physicochemical and immunochemical identification of the substances in serum exhibiting insulin-like activity has been formidable. These substances are apparently not stored in a specific organ site (8) (9) (10) and exist in serum in trace quantities. In 1968 (4) we reported physicochemical similarities among the variously described forms of serum insulin-like activity and elected to employ the term originally used by Froesch and co-workers (11) , "nonsuppressible insulin-like activity" (NSILA) 1 to collectively refer to this phenomenon; that is, insulin-like activity not suppressed by the presence of excess insulin antibody. Shortly thereafter, Jakob et al. (12) further clarified this term (NSILA) by demonstrating the existence of two molecular species in serum exhibiting NSILA, one a large molecular weight protein comprising 90-95% of total serum NSILA, the other a small molecular weight protein. The small molecular weight form has been subsequently purified to three protein bands by disk gel electrophoresis and assayed at a specific activity of 450 mU/mg (13) . Purification of the large molecular weight form of NSILA has not heretofore been reported. This paper describes the preparative purification of the large molecular weight protein exhibiting NSILA and thus opens the door to the development of more precise and specific immunochemical and cell-receptor assays by which to define its biological significance.
METHODS
Fat pad segment bioassay. The purification of serum of the peripheral portions of the fat pad into [8] [9] [10] [11] [12] segimieints; after mixing of 80-120 scgtisIets, 3 seogmlents at a time were blotted on filter pal)er anId iplaced inito pire\eighe(l incubation flasks which were agaiin weighed before incubation. Each bioassay consisted of an insulii standard curve, 25-150 ,uU/ml, plus unknow-n samples all assaved in triplicate.
Utnknown saimples were eqjuilibrated by dials-is against the l)ioassay btiffer and dilutte( appropiriately before bioassay.
A nianiifol(d was conlstruicted to permit sinniultalneous gassinig of all samples. Over a 3-yr l)eriod, eiploying 125-170 g Texas ran(lom-bred (Sprague-D)awley derived) rats, the inidex of precision (X) of this bioassay ranged from 0.08 to 0.16. The purified porcinie insulin stanidard (PJ5589, 21.7 U/mg) used was a gift of Dr. -Mary Root, Eli Lilly and Company, Iindiainapolis, Iild. Guin'ea pig ilnsuliin aintiseruiim was developed utilizing this inlsulitn as antigen ; tlis antiserum was used at a final dilutioin of 1: 1,000 (1 ,.d added to 1 ml incubation mediumii) w-hich su)pr-essed the activity of 500 JLU/ml of added insulill.
Immunoreactive insulin was determiinled bv the double antibody method modified by Soeldiner and Sloane (14) .
Sulfation factor assay. The hlypoplhysectoimiized rat costal cartilage assay previously modified by Daughaday et al.
(15) was used to assess sulfatioin factor activity (somatomedin-C). Hypophysectom-nized random-bred male rats (80 g) were obtained from Charles River Breediing Laboratories (Wilmington, Mass.) and used in the assay 14-21 days after pituitary ablation.
Starting mttatcrial. Blood bank. plasma was frozeni and tlhawed in 3.2-liter quantities; the fibrin wh-icil formed was separated from the serum by filtratioin througlh glass wool at 4°C after which 400-imil volutimes of seruml were e(luilibrated with 0.01 2M sodiuiim phosphate buffer -0.14 -M NaCl, pH 6.8, by dialysis in desulfurized casing against f-lve volumes of buffer, changed every 12 h for tllree (lialvsis periods. This dialyzed serum was gently (legasse(I and(l clarifie(d by millipore filtration (0.45 uni) b)efore its aplplication to the first purification stel).
Colunin electroplioresis of serum w-as accomplished utilizing Sephadex G-10 as the supporting mecliuim in a coIntinuous buffer of Tris-EDTA-boric acid at p)H 8.9 (16).
The Uniphor (LKB IInstruIments, IInc., Rockville, MId.) column electrophoresis apparatus w-as employed with a 2.5 X 45-cm gel column cooled to 4°C. After application of 3 ml serum (equilibrated by dialysis against the electrophoresis buffer) to the top (cathode end) of the columnl, electrophoresis was performed at a potential gradicnt of 300 V, 36 mA, for 22 h. Descending elutioin w-as then accomplished with electrophoresis buffer at a flow rate of 8 ml/h and monitored at 280 nm. The resultinig clhromatogram was arbitrarily divided into three fractions and( assayed for both suppressible and NSILA after concenitratioin in a microultrafiltration apparatus (Amicon Corp., Scientific Systems Div., Lexington, 'Mass.) with a UNM-2 membDranie and dialysis against bioassay buffer.
Pr-cparative Dowcx 50 adsorption clironmatlograpliy. The cationic polystyrene sulfoinic acid ion-exclhange resiin, Dowex 50 X 8, 50-100 mesh, wvas repeatedly cycled through H' and Na+ forms by washing with 4 N HCl and 4 N NaOH to remove chromogen. After the last Na+ cycle, the resin was washed extensively with distilled-deionized H20 until the effluent pH < 9.0 and was then poured into 3-liter preparative columns, 7.5 X 70 cm, fitted with flow-adapters and 2. (19) . Gels were stained with 0.5% Coomassie Blue in 25% methanol plus 10% TCA, and destained by diffusion; SDS gels were fixed in 10%o TCA overnight before staining.
RESULTS
Before the development of a scheme for purification of a trace serum protein with NSILA, a series of electrophoretic separations was performed to clarify the distinction between endogenous circulating insulin and NSILA, and to assess potential alteration in total NSILA recovery after addition of insulin to serum before fractionation. The results of five such studies are summarized in Fig. 1 . Panel A depicts the column electropherogram plus the observed insulin-like activity of the three arbitrarily selected fractions (I-III) resulting from electrophoresis of 3 ml serum. Total serum insulin-like activity before electroplhoresis averaged 517+26 uU/ml SE (n = 4). Recovery of total serum activity in the Preparative Dowex 50 adsorption chromatography. Several workers (4, 12, 20, 21 ) have confirmed to variable extents the original observation of Antoniades and Gundersen (21) that a major portion of serum insulinlike activity reversibly adsorbs to Dowex 50; however, this exchange process has not been sufficiently characterized to allow design of a system on a preparative scale. Several studies were therefore performed to characterize the properties of this exchange process. Table I lists the results of Dowex 50 chromatography of serum performed at varying pH between 6 and 8. At the lower pH range (6.19 -6.37) serum NSILA was completely adsorbed, whereas, progressively less adsorption occurred at neutral and alkaline pH. At pH 7.9 only 48.6% of the serum NSILA was adsorbed.
From these results it appeared that the optimal pH at which to perform Dowex 50 adsorption chromatography of serum NSILA was between 6.0 and 6.6. Since serum must be equilibrated by dialysis against the appropriate phosphosaline buffer before chromatography, a pH of 6.8 was eventually selected because of occasional troublesome precipitation of serum protein during dialysis at pH less than 6.8.
The studies characterizing optimal volume relationships during Dowex 50 serum chromatography are illustrated in Fig. 2 . In this study, increasing volumes of serum from 1 to 16 ml were chromatographed through a Dowex column of 30 ml bed volume at pH 6.8, and the adsorbed and nonadsorbed fractions were analyzed for protein content and NSILA. In the panel A of Fig. 2 the saturation curves for total adsorbed protein differs from that found for adsorbed serum NSILA: the one-half saturation for adsorbed protein (k.) was 2 ml whereas one-half saturation for adsorbed NSILA (kn) was 3.6 ml, indicating a higher binding capacity of serum NSILA for the resin than the other species of adsorbed serum protein.
To further characterize this binding, a Scatchard plot of the data was constructed as depicted in panel B, Fig.  2 On the basis of these experiments, a preparative chromatographic system was constructed employing resin bed volumes of 3 liters, allowing adsorption chromatography of 400 ml equilibrated serum per column per day.
The results of 41 successive preparative chromatographic procedures are summarized in Fig. 3 . The mean yield of adsorbed serum protein for each 400 ml processed was 192±+16 mg (SE) determined gravimetrically; the mean biologic specific activity was 0.48±0.09 mU NSILA/mg (Table II) . The heterogeneity of this ad- FIGURE 2 A study of the binding affinity and saturation kinetics of Dowex 50 for serum NSILA. In panel A, increasing volumes of serum were chromatographed through a resin bed volume of 30 ml (11 g Dowex dry wt) at pH 6.8. Total adsorbed protein (@*) showed a half-saturation (k.) =2 ml; the half-saturation (0) for NSILA (kn) = 3.6 ml. NSILA after adsol-ptioni chromnatographly w-as hiighly significanit (P < 0.001); however, the decrease in SFA and IRI was not significant. This data, theni, demonstrates a clear difference in the clhemical behavior of NSILA and SFA, and suggests that the miiajor portion of serum NSILA is not representative of SFA. Preparative Sephadex G-200 filtrationi of the adsorbed protein fraction in an alkalinie (pH 8.9) buffer of high ionic strength provided the next purification step. The standardization of this s-stem pluis a representative chromatogram is illtustrated in Fig. 5 . NSILA exhibited a Kav = 0.447+0.005 (i = 4) in this preparative system, corresponding to a mol wN-t approximnating 90,000.5 To corroborate these results a radiolabeled preparation of purified NSILA'6vas added to the stanidardization sample and was found to fractionate as a silngle peak w-ith Kay = 0.442; this is illustrated in the tipper portion of Fig. 5 . The effluent fraction from 3.7 to 4.5 liters (Kav 0.330 -0.526) was thereafter pooled duirilng preparative In l)revious studies with gel filtration of various N\SILA prel)arations at neutral pH, we reported an estimated mol Nvt of 45,000 (4). This disagreement with the results reported herein is explained on the basis of the behavior of the hemidiaphragm bioassay w-hich was previously employed (4) ; that is, protein concenitrations above 2 g/100 ml are generally inhibitory to glucose uptake. In this earlier report the void volume fraction of the G-100 column contained the greatest protein content and when bioassayed was apparently inhibitory at the concentration employed.
This effect resulted in an apparent shift in peak NSILA to a higher Ka., corresponding to this lower molecular wveight estimate. We failed to recognize this important point when designing the hemidiaphragm bioassay of the gel filtration chromatograms. 6Purified NSILA was labeled by a modified method employing chloraiiie-T (22) .
procedures, concentrated by ultrafiltration to 100-200 ml, desalted by dialysis, and lyophilized. The mean yield (dry wNt) from 1 g applied protein (equivalent to 2.12 liters of starting serum) wsas 152±0.04 mg which exhiibited a mean biologic specific activity of 3.7 mU/mg protein. This active G-200 fraction contained five protein bands whlien assessed by standard disk gel electrophoresis (see iniset, Fig. 5 ) and seven banids on analytical SDS gel electrophoresis (nlot shown). No SFA was found in this fraction.
Isoelectric focuisinig of this G-200 fraction is showN-n in Fig. 6 . The major protein content focused at tlle acid end of the pH gradient, whereas, NSILA was recovered in the fraction correspondinig to a pH range of 5.9-6.5. Identical blanik experimenits (no G-200 fraction added) did not yield NSILA. The (6) 84411 (10) 3.70±0.31 (16) centrifuged, dialyzed against bioassay buffer, and assayed for NSILA. In this manner, the crude relative mobility (R,) for NSILA in these gels was estimated to range from 0.09 at 10% acrylamide to 0.34 at 5%. A plot of the relative mobility of NSILA and the four biologically inactive protein bands against the acrylamide concentration revealed nearly parallel lines indicating that separation was occurring largely on the basis of charge, and that the NISLA possessed a higher retardation coefficient relative to the contaminating proteins. Based upon this information a preparative acrylamide gel electrophoresis system was adopted as the final purification step. Fig. 7 depicts the most satisfactory gel system developed to date. NSILA elutes late and recovery of applied activity has been low, ranging from 16 to 38%. Biologic activity of this fraction has been stable, stored frozen in elution buffer at -20°C, and has varied among four experiments from 30 to 50 mU/mg protein. Insulin immunoreactivity has not been found in four separate preparations. Analytical gel electrophoresis of the active fraction has revealed a single protein band Analytical SDS gel electrophoresis of the purified NSILA was performed both in the presence and absence of mercaptoethanol, and revealed closely space doublet bands of 90,000 and 92,000 mol wt, in agreement with the G-200 filtration estimation (Fig. 5 ). It has not been possible to recover biologic activity from preparative modifications of this system; hence, it is unclear if only one or both of these protein bands exhibit NSILA. Table II summarizes the efficiency of the purification scheme developed to date. These data indicated an 8,700-fold purification and revealed the feasibility of obtaining 1 mg of purified NSILA from 1 liter of starting serum. Employing the specific activity of 50 mU/mg this yield represented a 14% recovery7 of starting NSILA. There exists no purification schemes for similar trace serum proteins by which comparison of recoveries can be made; however, the low recovery in the final step indicates the need for further modification. Finally, it is important to note that all NSILA fractions derived from this purification scheme were subjected to insulin immunoassay with completely negative results throughout. DISCUSSION The principal significance of this work lies in the purification and partial identification of the serum protein contributing to the major portion of NSILA. This protein has been purified to a biologic specific activity of 50 mU/mg and appears as a single band on discontinuous gel electrophoresis; however, the final product probably contains two closely related proteins as evidenced by a closely spaced doublet band on SDS gel electrophoresis.
Purification of a small molecular weight serum protein exhibiting NSILA was reported by Oelz et al. in 1972 (13) . This protein of 7,500 daltons was termed 'The highest specific activity found for purified NSILA was 50 mU/mg and the mean serum NSILA content for the serum pool employed was 0.350 mU/ml; therefore the serum NSILA concentration approximates 7 jg/ml (77 nM%) or 7 mg/liter.
Purification of Nonsuppressible Insulin-Like Activity NSILA-S becauise of its solubility in acid-ethanol (12) and was estimated to contribute 5-10% of the total serum NSILA (12, 13) . The remaining larger fraction, termed NSILA-P because of its precipitable behavior in acid-ethanol, was estimated to approximate 100,000 daltons (12) . It is conceivable that the NSILA protein purified in this study represents this NSILA-P fraction; however, further chemical characterization of both is required before this conclusion is possible.
The biological relationship of serum NNSILA to somatomedin activity has been questioned by several investigators; however, a similarity betweeni somatomedin and the NSILA protein purified here was not apparent. Somatomedin bioassays (radiosulfate uptake) were performed in three different laboratories on all protein fractions derived from this purification scheme and the results correspond in each laboratory; i.e., somatomedin activity did not adsorb to Dowex 50 in the first purification step as does NSILA, and all G-200 fractions were negative when assayed. Furthermore, purified somatomedin (4,000-8,000 daltons) appears to possess few if any of the chemical properties found for the NSILA purified in this study (23) .
A part of the identity problem in this area of insulinlike activity may reside in the effect of various purification schemes on the protein moiety being isolated. The scheme developed here differs in many respects from those developed for somatomedin and NSILA-S (23, 12 ). An important question raised in this respect concerns the failure to identify the small molecular weight form of NSILA (NSILA-S) in the scheme developed here. The dialysis and ultrafiltration steps were studied in detail but no NSILA was found in the filtrates. In addition, NSILA was localized in only one broad area of the column electropherogram of serum (Fig. 1) . Finally, attempts to dissociate NSILA activity in the active G-200 fraction by gel filtration in 7 M urea and 5 M acetic acid-0.15 MI NaCl (12, 24) failed to reveal a low molecular weight form.8 Further comparative speculation on the nature of serum NSILA can serve little useful purpose at this time; the solution to the questions raised will best be found once immunochemical tools become available.
In conclusion, the results of these studies verify the existence and protein nature of the major contributor of human serum NSILA and provide a scheme suitable for preparative purification. The nondissociable large molecular weight of this nonsuppressible insulin-like protein distinguishes it from smaller NSILA proteins previously isolated, NSILA-S (12) and somatomedin-C (23). Further chemical characterization plus the development of immunochemical and cell-membrane receptor methods for the more precise and specific study of this 8 Unpublished observations. substance should complete the necessary foundationi from which to eventually elucidate its metabolic role.
